↓ Skip to main content

Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial

Overview of attention for article published in Pediatric Rheumatology, May 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news
1 news outlet
policy
1 policy source
twitter
3 X users

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
158 Mendeley
Title
Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial
Published in
Pediatric Rheumatology, May 2019
DOI 10.1186/s12969-019-0325-6
Pubmed ID
Authors

Himanshu P. Upadhyaya, Lesley M. Arnold, Karla Alaka, Meihua Qiao, David Williams, Renata Mehta

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 158 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 158 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 29 18%
Student > Doctoral Student 19 12%
Student > Master 18 11%
Other 12 8%
Researcher 10 6%
Other 23 15%
Unknown 47 30%
Readers by discipline Count As %
Medicine and Dentistry 34 22%
Psychology 26 16%
Nursing and Health Professions 18 11%
Pharmacology, Toxicology and Pharmaceutical Science 9 6%
Social Sciences 5 3%
Other 15 9%
Unknown 51 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 January 2021.
All research outputs
#2,262,645
of 22,952,268 outputs
Outputs from Pediatric Rheumatology
#70
of 700 outputs
Outputs of similar age
#50,860
of 349,727 outputs
Outputs of similar age from Pediatric Rheumatology
#6
of 20 outputs
Altmetric has tracked 22,952,268 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 700 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 349,727 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.